about
Antileishmanial high-throughput drug screening reveals drug candidates with new scaffoldsStudies on protozoa in ancient remains--a reviewLeishmaniasis and climate change-case study: ArgentinaBacterial sepsis in patients with visceral leishmaniasis in Northwest Ethiopia.Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 inductionVisceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular ApproachesResurgence of cutaneous leishmaniasis in Israel, 2001-2012Parasite burden in hamsters infected with two different strains of leishmania (Leishmania) infantum: "Leishman Donovan units" versus real-time PCR.Cheminformatic models based on machine learning for pyruvate kinase inhibitors of Leishmania mexicana.The economic value of a visceral leishmaniasis vaccine in Bihar state, India.Differential Impact of LPG-and PG-Deficient Leishmania major Mutants on the Immune Response of Human Dendritic Cells.A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Carbon Dioxide Laser plus Glucantime on Cutaneous Leishmaniasis LesionsIsolated laryngeal leishmaniasis in immunocompetent patients: an underdiagnosed disease.Identification of Leishmania Species Isolated from Human Cutaneous Leishmaniasis in Mehran, Western Iran Using Nested PCR.The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genesβ-Nitrostyrenes as Potential Anti-leishmanial Agents.Identification of leishmania species using PCR assay on giemsa-stained slides prepared from cutaneous leishmaniasis patients.Autophagy in trypanosomatids.Human immunodeficiency virus and leishmaniasis.Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?Intracellular drug delivery in Leishmania-infected macrophages: Evaluation of saponin-loaded PLGA nanoparticles.Epidemiology of Cutaneous Leishmaniasis in a Colombian Municipality.[Kala azar - Lethal course of visceral leishmaniasis. Synchronous infection with Leishmania donovani/infantum complex and Leishmania major in a patient after Mediterranean vacation].Conventional therapy and promising plant-derived compounds against trypanosomatid parasites.Phlebotominae of epidemiological importance in cutaneous leishmaniasis in northwestern Argentina: risk maps and ecological niche models.New 5-(nitroheteroaryl)-1,3,4-thiadiazols containing acyclic amines at C-2: synthesis and SAR study for their antileishmanial activity.Primary laryngeal leishmaniasis: an unusual diagnosis at an unusual site.Leishmania in a Patient with Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia.Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasisMucosal leishmaniasis of the tongue caused byLeishmania infantumin an immunocompetent woman
P2860
Q28473835-BD04FD7C-B59E-4649-AA4F-26D537C52DB0Q28660436-F43D5B0D-F625-4A82-943D-43A489015E8AQ30395227-F0FDF1C9-7AFC-4333-BA48-BAEEF593C2D1Q33660792-05F7B02F-FEEE-4EE7-A247-68F339A10A23Q33736426-BB05F7B4-4D8A-45B7-A9F8-C6F53262168CQ34076804-E3B52325-3452-4A4D-BC83-CDCDD4DDD8BFQ34320422-79DAE62B-B41C-4265-A9B5-C76275BBE4A4Q34462414-1A05F5A4-FC50-4621-A7A2-4A56D5E4C5CCQ34477714-AAB8C8C1-D9F4-4B72-BB49-8308DB839902Q35771782-000DED27-5114-48E9-841D-57F4B44CFBDAQ35859111-62A7D19D-8D6D-4464-A182-3A266D85CA67Q36009160-AE983D1A-CD97-4515-84CA-6751A80FD189Q36805012-78DC84A0-0827-48D3-A84B-B22C7B57F947Q36809220-287D8D8B-D069-41EC-9377-46C54E3202DAQ37160811-12E7E4B8-744D-40CA-A052-F8E1A1AF0D19Q37224367-9C6AF49D-0269-4489-A005-406EDA733561Q37459415-6CF8650A-0DE9-46FC-BD7C-2DEABEA3460FQ37512274-737C4B74-2BFA-470B-B678-B3045A61BA80Q37798456-3BEC3C39-B4D7-4124-AC17-8125A7953C24Q38188571-71247011-A83B-4965-9323-277350B10661Q39443647-0C1A0978-7000-40E5-9AFD-A90A0C90EC4FQ40078255-77ECB986-AFC9-4CE8-9850-CF91CA38DA3AQ40271417-B636DD2B-190E-47E1-BCF8-0A044FF023DBQ42116673-557022FD-3603-4A40-9F44-E41CDA9CF2D9Q45843877-8D7E73D4-48FB-4420-A791-04E08F6784D4Q45895157-8A0399F1-0D4A-40B7-9AC7-05288FEA0323Q51438086-A1A10076-D3CA-4C93-9944-DC15F5B373E7Q54975035-3288FC2B-0BAF-4D01-BC5F-49FA6FA6D2FAQ57190987-941344BC-EED5-4517-BD35-DB8F5D0C1818Q57741999-7B68F1C6-3CBB-4537-80C4-E14BF1996B14
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Leishmaniasis.
@ast
Leishmaniasis.
@en
type
label
Leishmaniasis.
@ast
Leishmaniasis.
@en
prefLabel
Leishmaniasis.
@ast
Leishmaniasis.
@en
P2860
P1476
Leishmaniasis.
@en
P2093
Charles Mallia Azzopardi
Tonio V Piscopo
P2860
P304
P356
10.1136/PGMJ.2006.047340CORR1
P407
P577
2007-02-01T00:00:00Z